MannKind wins FDA approval for Furoscix ReadyFlow autoinjector for edema

The device is described as the first and only autoinjector delivering IV-equivalent diuretic therapy for adults with edema linked to heart failure or chronic kidney disease.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.